Literature DB >> 17880844

The emergence of chagas disease in the United States and Canada.

Louis V Kirchhoff1, Richard D Pearson.   

Abstract

Year:  2007        PMID： 17880844     DOI： 10.1007/s11908-007-0053-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  30 in total

Review 1.  Safety of the blood supply in Latin America.

Authors:  Gabriel A Schmunis; Jose R Cruz
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 2.  The future of Chagas disease control.

Authors:  Chris J Schofield; Jean Jannin; Roberto Salvatella
Journal:  Trends Parasitol       Date:  2006-10-16

3.  Heart transplantation for chronic Chagas' heart disease.

Authors:  E A Bocchi; G Bellotti; A O Mocelin; D Uip; F Bacal; M L Higuchi; V Amato-Neto; A Fiorelli; N A Stolf; A D Jatene; F Pileggi
Journal:  Ann Thorac Surg       Date:  1996-06       Impact factor: 4.330

4.  Increased specificity of serodiagnosis of Chagas' disease by detection of antibody to the 72- and 90-kilodalton glycoproteins of Trypanosoma cruzi.

Authors:  L V Kirchhoff; A A Gam; R A Gusmao; R S Goldsmith; J M Rezende; A Rassi
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

5.  Chagas disease after organ transplantation--United States, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-03-15       Impact factor: 17.586

6.  Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States.

Authors:  Louis V Kirchhoff; Patricia Paredes; Abel Lomelí-Guerrero; Mario Paredes-Espinoza; Carlos S Ron-Guerrero; Manuel Delgado-Mejía; José G Peña-Muñoz
Journal:  Transfusion       Date:  2006-02       Impact factor: 3.157

7.  American trypanosomiasis (Chagas' disease) in Central American immigrants.

Authors:  L V Kirchhoff; A A Gam; F C Gilliam
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

8.  Possible oral transmission of acute Chagas' disease in Brazil.

Authors:  M A Shikanai-Yasuda; C B Marcondes; L A Guedes; G S Siqueira; A A Barone; J C Dias; V Amato Neto; J E Tolezano; B A Peres; E R Arruda Júnior
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1991 Sep-Oct       Impact factor: 1.846

9.  Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction.

Authors:  Alejandro G Schijman; Jaime Altcheh; Juan M Burgos; Miguel Biancardi; Margarita Bisio; Mariano J Levin; Héctor Freilij
Journal:  J Antimicrob Chemother       Date:  2003-08-13       Impact factor: 5.790

10.  Autochthonous transmission of Trypanosoma cruzi, Louisiana.

Authors:  Patricia L Dorn; Leon Perniciaro; Michael J Yabsley; Dawn M Roellig; Gary Balsamo; James Diaz; Dawn Wesson
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883
View more
  4 in total

1.  Anti-trypanosomatid activity of ceragenins.

Authors:  Diana Lara; Yanshu Feng; Julia Bader; Paul B Savage; Rosa A Maldonado
Journal:  J Parasitol       Date:  2010-06       Impact factor: 1.276

2.  Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype.

Authors:  Fnu Nagajyothi; Mahalia S Desruisseaux; Niranjan Thiruvur; Louis M Weiss; Vicki L Braunstein; Chris Albanese; Mauro M Teixeira; Cecilia J de Almeida; Michael P Lisanti; Philipp E Scherer; Herbert B Tanowitz
Journal:  Obesity (Silver Spring)       Date:  2008-09       Impact factor: 5.002

3.  2,3-diphenyl-1,4-naphthoquinone: a potential chemotherapeutic agent against Trypanosoma cruzi.

Authors:  Enrique I Ramos; Kristine M Garza; R L Krauth-Siegel; Julia Bader; Luiz E Martinez; Rosa A Maldonado
Journal:  J Parasitol       Date:  2009-04       Impact factor: 1.276

Review 4.  Chagas disease cardiomyopathy: immunopathology and genetics.

Authors:  Edecio Cunha-Neto; Christophe Chevillard
Journal:  Mediators Inflamm       Date:  2014-08-19       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.